776 related articles for article (PubMed ID: 29552930)
1. Cardiac implantable electronic device and vascular access: Strategies to overcome problems.
Kusztal M; Nowak K
J Vasc Access; 2018 Nov; 19(6):521-527. PubMed ID: 29552930
[TBL] [Abstract][Full Text] [Related]
2. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
[TBL] [Abstract][Full Text] [Related]
3. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S
Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276
[TBL] [Abstract][Full Text] [Related]
4. The dilemma of transvenous cardiac rhythm devices in hemodialysis patients: time to consider the epicardial approach?
Asif A; Salman LH; Lopera GG; Carrillo RG
Kidney Int; 2011 Jun; 79(12):1267-9. PubMed ID: 21625255
[No Abstract] [Full Text] [Related]
5. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
[TBL] [Abstract][Full Text] [Related]
6. Twenty-Seven Years Experience With Transvenous Pacemaker Implantation in Children Weighing <10 kg.
Konta L; Chubb MH; Bostock J; Rogers J; Rosenthal E
Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003422. PubMed ID: 26857908
[TBL] [Abstract][Full Text] [Related]
7. Prevention of Sudden Cardiac Death: Focus on the Subcutaneous Implantable Cardioverter-Defibrillator.
Adduci C; Palano F; Silvetti G; Cosentino P; Francia P
High Blood Press Cardiovasc Prev; 2020 Aug; 27(4):291-297. PubMed ID: 32519207
[TBL] [Abstract][Full Text] [Related]
8. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.
Nakhoul GN; Schold JD; Arrigain S; Harb SC; Jolly S; Wilkoff BL; Nally JV; Navaneethan SD
Clin J Am Soc Nephrol; 2015 Jul; 10(7):1119-27. PubMed ID: 26111859
[TBL] [Abstract][Full Text] [Related]
9. Saving lives and reducing inappropriate device therapy: the MADIT family of implantable cardioverter-defibrillator and cardiac resynchronization therapy trials.
Moss AJ
Cardiol J; 2013; 20(3):217-9. PubMed ID: 23788293
[No Abstract] [Full Text] [Related]
10. Central Venous Stenosis after Hemodialysis: Case Reports and Relationships to Catheters and Cardiac Implantable Devices.
Pacilio M; Borrelli S; Conte G; Minutolo R; Musumeci A; Brunori G; Veniero P; De Falco V; Provenzano M; De Nicola L; Garofalo C
Cardiorenal Med; 2019; 9(3):135-144. PubMed ID: 30814478
[TBL] [Abstract][Full Text] [Related]
11. The Italian subcutaneous implantable cardioverter-defibrillator survey: S-ICD, why not?
Botto GL; Forleo GB; Capucci A; Solimene F; Vado A; Bertero G; Palmisano P; Pisanò E; Rapacciuolo A; Infusino T; Vicentini A; Viscusi M; Ferrari P; Talarico A; Russo G; Boriani G; Padeletti L; Lovecchio M; Valsecchi S; D'Onofrio A;
Europace; 2017 Nov; 19(11):1826-1832. PubMed ID: 28011803
[TBL] [Abstract][Full Text] [Related]
12. Implantable cardiac electronic device therapy for patients with a systemic right ventricle.
Barracano R; Brida M; Guarguagli S; Palmieri R; Diller GP; Gatzoulis MA; Wong T
Heart; 2020 Jul; 106(14):1052-1058. PubMed ID: 32269130
[TBL] [Abstract][Full Text] [Related]
13. Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort study.
Özcan C; Raunsø J; Lamberts M; Køber L; Lindhardt TB; Bruun NE; Laursen ML; Torp-Pedersen C; Gislason GH; Hansen ML
Europace; 2017 Jun; 19(6):1007-1014. PubMed ID: 28073883
[TBL] [Abstract][Full Text] [Related]
14. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous placement of leadless pacemaker and dialysis catheter in patient with exhausted vasculature.
Bednarczyk D; Kuliczkowski W; Letachowicz K; Dzidowski M; Witkowski T; Krajewska M; Kusztal M; Mysiak A; Ściborski K; Mitkowski P
J Vasc Access; 2021 Jan; 22(1):147-150. PubMed ID: 31868084
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous implantable cardioverter defibrillator for dialysis patients: a strategy to reduce central vein stenoses and infections.
Dhamija RK; Tan H; Philbin E; Mathew RO; Sidhu MS; Wang J; Saour B; Haqqie SS; Beathard G; Yevzlin AS; Salman L; Boden WE; Siskin G; Asif A
Am J Kidney Dis; 2015 Jul; 66(1):154-8. PubMed ID: 25911316
[TBL] [Abstract][Full Text] [Related]
17. Placement issues of hemodialysis catheters with pre-existing central lines and catheters.
Aurshina A; Hingorani A; Alsheekh A; Kibrik P; Marks N; Ascher E
J Vasc Access; 2018 Jul; 19(4):366-369. PubMed ID: 29542366
[TBL] [Abstract][Full Text] [Related]
18. Predictors for early mortality and arrhythmic events in patients with cardiac resynchronization therapy with defibrillator: A two center cohort study.
Gunten SV; Theuns DA; Kühne M; Reichlin T; Sticherling C; Schaer B
Cardiol J; 2019; 26(6):711-716. PubMed ID: 30484267
[TBL] [Abstract][Full Text] [Related]
19. Venous Hemodialysis Catheters and Cardiac Implantable Electronic Devices: Avoiding a High-Risk Combination.
Saad TF; Weiner HL
Semin Dial; 2017 May; 30(3):187-192. PubMed ID: 28229483
[TBL] [Abstract][Full Text] [Related]
20. Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort.
Varma N; Mittal S; Prillinger JB; Snell J; Dalal N; Piccini JP
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
